In January, after the DermaSensor became the first artificial intelligence (AI)-enabled device cleared by the US Food and Drug Administration (FDA) to evaluate lesions suggestive of skin cancer, the ...

TALLAHASSEE, Fla.--(BUSINESS WIRE)--DermaSensor Inc., a health technology company equipping primary care physicians (PCPs) with a non-invasive device for evaluating suspicious skin lesions and a proud ...

Symmetrical—lesions appear to be distributed in a similar arrangement on differing sides of the body (Figure 3, see slideshow) Once the configuration and distribution has been determined, the next ...

Read practical tips and guidance from Cancer Research UK written to help GPs recognise and refer suspected skin cancers in a timely way.

Please provide your email address to receive an email when new articles are posted on . The device is a handheld tool that uses spectroscopy and algorithms to test worrisome skin lesions for cancer.

An artificial intelligence (AI)–enabled handheld elastic scattering spectroscopy (ESS) device improved the sensitivity for skin cancer diagnosis and management by primary care physicians (PCPs), with ...

A mobile app that uses artificial intelligence, AI, to analyze images of suspected skin lesions can diagnose melanoma with very high precision, according to a new study. A mobile app that uses ...

Please provide your email address to receive an email when new articles are posted on . The device achieved an overall sensitivity of 97.04%. The device had an overall specificity of 26.22%, a ...